Healthcare Providers' and Frontline Workers' Experiences of an Ebola Vaccine Trial in the Boende Health District of the Democratic Republic of the Congo.

Autor: Zola Matuvanga T; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Bolombo FB; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Paviotti A; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Larivière Y; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Lemey G; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Salloum M; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Osang'ir BI; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Esanga E; Division Provinciale de la Santé de la Tshuapa, Ministry of Health of the Democratic Republic of the Congo, Kinshasa, Democratic Republic of the Congo., Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium., Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Van Geertruyden JP; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium.

Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2024 Jul 02; Vol. 111 (3), pp. 578-588. Date of Electronic Publication: 2024 Jul 02 (Print Publication: 2024).

An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations.

Autor: Lemey G; Global Health Institute, University of Antwerp, Antwerpen, Belgium.; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerpen, Belgium., Larivière Y; Global Health Institute, University of Antwerp, Antwerpen, Belgium ynke.lariviere@uantwerpen.be.; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerpen, Belgium., Osang'ir BI; Global Health Institute, University of Antwerp, Antwerpen, Belgium.; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerpen, Belgium., Zola T; Global Health Institute, University of Antwerp, Antwerpen, Belgium.; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Kimbulu P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Danoff E; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Tchuma Y; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the)., Ravinetto R; Public Health, Institute of Tropical Medicine, Antwerp, Belgium.; School of Public Health, University of the Western Cape, Cape Town, South Africa., Van Damme P; Centre for the Evaluation of Vaccination, University of Antwerp, Antwerpen, Belgium., Van Geertruyden JP; Global Health Institute, University of Antwerp, Antwerpen, Belgium., Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the).

Publikováno v: BMJ global health [BMJ Glob Health] 2024 Jun 10; Vol. 9 (6). Date of Electronic Publication: 2024 Jun 10.

Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo.

Autor: Zola Matuvanga T; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo. Electronic address: zola.matuvanga@unikin.ac.cd., Larivière Y; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Lemey G; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Isekah Osang'ir B; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Mariën J; Department of Biology, Evolutionairy Ecology group, University of Antwerp, Wilrijk, Belgium; Department of Biology, Royal Museum for Central Africa, Tervuren, Belgium., Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Meta R; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Van Geertruyden JP; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.

Publikováno v: Vaccine [Vaccine] 2024 Jan 25; Vol. 42 (3), pp. 481-488. Date of Electronic Publication: 2023 Dec 31.

Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.

Autor: Larivière Y; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Matuvanga TZ; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The. Electronic address: zola.matuvanga@unikin.ac.cd., Lemey G; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Osang'ir BI; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Vermeiren PP; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Meta R; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Kimbulu P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Esanga E; Division Provinciale de la Santé de la Tshuapa, Democratic Republic of the Congo, The., Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Van Geertruyden JP; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium., Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The., Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, The.

Publikováno v: Vaccine [Vaccine] 2023 Dec 12; Vol. 41 (51), pp. 7587-7597. Date of Electronic Publication: 2023 Nov 22.

Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.

Autor: Zola Matuvanga T; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Larivière Y; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium. Electronic address: ynke.lariviere@uantwerpen.be., Lemey G; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., De Bie J; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Milolo S; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo., Meta R; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo., Esanga E; Tshuapa Provincial Health Division, The Democratic Republic of the Congo., Vermeiren PP; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Thys S; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Van Geertruyden JP; Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk, Belgium., Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium., Maketa V; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo., Matangila J; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo., Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo., Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, The Democratic Republic of the Congo.

Publikováno v: Vaccine [Vaccine] 2022 May 31; Vol. 40 (25), pp. 3470-3480. Date of Electronic Publication: 2022 May 09.